is metformin a glp-1 medication and Glucagon-like peptide-1 (GLP-1) inhibit Adenosine Comparing Ozempic, Wegovy and Other

Inhibition by phenylarsine oxide

141 The effect of GLP-1 RA on synaptic plasticity is partly due to the GLP-1R

Subscribe today to stay ahead with trusted insights and tools

People with type 2 diabetes using GLP-1 receptor agonists, DPP-IV inhibitors or multiple therapies combining metformin, sulfonylureas, repaglinide, alpha-glucosidase inhibitors or thiazolidinediones from 2006 to 2018 were included

Mo1908: glucagon-like peptide-1 receptor agonist use in patients with perianal fistulizing Crohns disease is well tolerated and leads to weight loss and clinical improvement in fistula activity

doi:10.1016/j.clinthera.2011.04.024 123